| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Olmesartan Medoxomil | FAERS: 10 | US FAERS | |
| 2 | rofecoxib | FAERS: 5 | OFFSIDES US FAERS | |
| 3 | Isotretinoin | FAERS: 3 | US FAERS | |
| 4 | Alendronate | FAERS: 2 | US FAERS | |
| 5 | Benicar hct | FAERS: 2 | US FAERS | |
| 6 | Dabigatran | FAERS: 2 | US FAERS | |
| 7 | Lamotrigine | FAERS: 2 | US FAERS | |
| 8 | Metoprolol | FAERS: 2 | US FAERS | |
| 9 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 10 | Doxazosin | FAERS: 1 | US FAERS | |
| 11 | Finasteride | FAERS: 1 | US FAERS | |
| 12 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 13 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 14 | Irinotecan | FAERS: 1 | US FAERS | |
| 15 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 16 | Tacrolimus | FAERS: 1 | US FAERS | |
| 17 | Vemurafenib | FAERS: 1 | US FAERS | |
| 18 | apixaban | FAERS: 1 | US FAERS | |
| 19 | candesartan cilexetil | FAERS: 1 | US FAERS | |
| 20 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 21 | miglustat | FAERS: 1 | US FAERS | |
| 22 | Bupropion | OFFSIDES | ||
| 23 | Carnitine | OFFSIDES | ||
| 24 | Cefadroxil | OFFSIDES | ||
| 25 | Celiprolol | OFFSIDES | ||
| 26 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 27 | Molsidomine | OFFSIDES | ||
| 28 | Nortriptyline | OFFSIDES | ||
| 29 | Raloxifene Hydrochloride | OFFSIDES | ||
| 30 | Salmeterol Xinafoate | OFFSIDES | ||
| 31 | Sodium picosulfate | OFFSIDES | ||
| 32 | Tretinoin | OFFSIDES | ||
| 33 | Ubiquinone | OFFSIDES | ||
| 34 | Zoledronic Acid | OFFSIDES | ||
| 35 | dihydroxyaluminum sodium carbonate | OFFSIDES | ||
| 36 | dimemorfan | OFFSIDES | ||
| 37 | moexipril | OFFSIDES | ||
| 38 | sennoside A&B | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.